The vaccine storage & packaging market was valued at USD 25.53 billion in 2024 and is estimated at USD 28.41 billion in 2025. It is projected to reach USD 75.61 billion by 2034, growing at a CAGR of 11.49% over the 2025–2034 forecast period. North America was the largest market in 2024, and major players include Gerresheimer, SCHOTT Pharma AG & Co. KGaA, Sealed Air Corporation, Stevanato, and Thermo Fisher Scientific.

Vaccine storage and packaging refer to specialized processes and materials used to preserve the vaccine potency, safety, and efficacy from manufacture to administration. Proper storage typically maintains vaccines between 2°C and 8°C using refrigerated transport, cold boxes, and vaccine freezers as part of the cold chain. Some vaccines, such as certain mRNA-based ones, require ultra-cold storage at temperatures as low as -70°C. Packaging includes temperature-sensitive labels and insulated packaging, and exposure to incorrect temperatures or physical damage can degrade vaccine components and render them ineffective. Effective storage and packaging also support logistical efficiency, especially in remote or resource-limited areas, enabling timely immunization campaigns against diseases such as polio, measles, and COVID-19.

Demand Drivers

The report names the rising incidence of chronic diseases, increasing healthcare spending, and growing government ventures into vaccination programs as key factors. The World Health Organization stated that noncommunicable diseases killed at least 43 million people in 2021, driving governments and health organizations to expand immunization programs. Governments worldwide, such as the U.S. and India, are actively supporting vaccination projects by allocating substantial funding for research and development, procurement, and distribution of vaccines. Greater volume and variety of vaccines increase the need for specialized storage such as ultra-low temperature freezers and smart refrigeration units, and for advanced packaging such as multi-dose vials and temperature-controlled containers.

Higher healthcare spending enables the procurement of larger vaccine quantities and the introduction of new vaccines. Health spending in the U.S. increased by 7.5% in 2023 to $4.9 trillion, or $14,570 per capita.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/vaccine-storage-packaging-market

Segment and Regional Highlights

The storage segment held the largest revenue share in 2024, as governments, healthcare providers, and pharmaceutical companies invested heavily in reliable cold chain infrastructure. By end use, distributors dominated the revenue share because of their role in bridging the gap between manufacturers and healthcare providers, managing large-scale logistics networks that handle vaccines requiring stringent temperature control. North America held 38.91% of the global market in 2024, owing to strong healthcare infrastructure and government initiatives, and the U.S. held the largest share in the region because of large-scale immunization programs, including routine childhood vaccinations and pandemic preparedness efforts.

Risks and the Role of AI

The risk of loss of vaccine potency due to temperature excursions outside the recommended storage ranges may hamper market growth. AI is highlighted as a way to enhance precision in vaccine storage through predictive maintenance across the cold chain, and to optimize packaging design through data-driven simulations for better thermal protection. Advances in material science are described as a lucrative opportunity, and Europe is projected to grow at a rapid CAGR from 2025 to 2034 owing to high vaccination coverage and stringent regulatory requirements.

Key Players in the Vaccine Storage & Packaging Market

•         Amcor

•         B Medical Systems

•         Becton Dickinson

•         Corning Incorporated

•         Gerresheimer

•         Lineage, Inc.

•         NIPRO

•         Piramal Glass

•         SCHOTT Pharma AG & Co. KGaA

•         Sealed Air Corporation

•         SiO2 Materials Science

•         Stevanato

•         Thermo Fisher Scientific

Conclusion

The vaccine storage & packaging market is projected to grow from USD 28.41 billion in 2025 to USD 75.61 billion by 2034 at a CAGR of 11.49%. Expanding vaccination efforts, rising healthcare spending, and the need to keep temperature-sensitive products stable all point to sustained demand for reliable storage and packaging. Stakeholders that address temperature risk while scaling capacity will be best placed to benefit, with the Polaris Market Research report providing detailed segment and regional context.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market